BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma

由 Lukas, Rimas V, Merrell, Ryan T
發表在 CNS Oncol (2018)

NT-15 STEREOTACTIC LASER THERMAL ABLATION OF RECURRENT POSTERIOR FOSSA METASTATIC LESION: DESCRIPTION OF NEW TECHNOLOGY FOR INFRATENTORIAL TUMORS REFRACTORY TO CONVENTIONAL THERAPI...

由 Eliyas, Javed Khader, Bailes, Julian, Merrell, Ryan, O'Leary, Shaun
出版 2014

MNGI-03. PATIENT PARAMETERS ASSOCIATED WITH TUMOR GROWTH IN INCIDENTAL MENINGIOMA

由 Kamson, David, Yuen, Carlen, Castillo-Saavedra, Laura, Wilmington, Andrew, Walker, Matthew, Merrell, Ryan
發表在 Neuro Oncol (2018)

Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature

由 Shakur, Sophia F., Bit-Ivan, Esther, Watkin, William G., Merrell, Ryan T., Farhat, Hamad I.
出版 2013

Combined Open and Endoscopic Endonasal Skull Base Resection of a Rare Endometrial Carcinoma Metastasis

由 Stamates, Melissa M., Lee, John M., Merrell, Ryan T., Shinners, Michael J., Wong, Ricky H.
發表在 J Neurol Surg Rep (2018)

MNGI-03. ESTROGEN HORMONE REPLACEMENT THERAPY IN INCIDENTAL MENINGIOMA - A GROWTH RATE ANALYSIS

由 Kamson, David, Yuen, Carlen, Castillo Saavedra, Laura, Jenkins Vogel, Tilley, Merrell, Ryan, Walker, Matthew
發表在 Neuro Oncol (2019)

Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis

由 Dresser, Laura, Yuen, Carlen Amy, Wilmington, Andrew, Walker, Matthew, Vogel, Tilley Jenkins, Merrell, Ryan T., Kamson, David Olayinka
發表在 Sci Rep (2020)

Standardizing Care of Neuro-oncology Patients Using a Customized Electronic Medical Record Toolkit

由 Merrell, Ryan T., Simon, Kelly Claire, Martinez, Nina, Vazquez, Rosa Maria, Hadsell, Bryce, Epshteyn, Alexander, Wilk, Gary, Frigerio, Roberta, Maraganore, Demetrius M.
發表在 Mayo Clin Proc Innov Qual Outcomes (2021)

RT-08 PROTON THERAPY (PT) LARGE-VOLUME RE-IRRADIATION FOR RECURRENT GLIOMA: OVERALL SURVIVAL (OS) AND TOXICITY OUTCOMES

由 Desai, Brijal, Rockne, Russell, Rademaker, Alfred, Raizer, Jeffrey, Paleologos, Nina, Merrell, Ryan, Grimm, Sean, Azeem, Syed, Hartsell, William, Sweeney, Patrick, Swanson, Kristin, Gondi, Vinai
發表在 Neuro Oncol (2014)

PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA

由 Lassman, Andrew, Roberts-Rapp, Lisa, He, Lei, Lu, Xin, van den Bent, Martin, Papadopoulos, Kyriakos, Merrell, Ryan, Kumthekar, Priya, Reardon, David, Gomez, Erica, Fischer, JuDee, Jiang, Fang, Zha, Zheng, Bhathena, Anahita, Holen, Kyle, Ansell, Peter, Gan, Hui K, Scott, Andrew
發表在 Neuro Oncol (2017)

ATCT-34 BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB PLUS VORINOSTAT VERSUS BEVACIZUMAB ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA

由 Wu, Jing, Puduvalli, Vinay K., Yuan, Ying, Armstrong, Terri, Walker, Brenda, Upshaw, Charlene, Giglio, Pierre, Colman, Howard, Groves, Morris D., Raizer, Jeffrey, Walbert, Tobias, Tran, David, Avgeropoulos, Nicholas, Iwamoto, Fabio, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Paleologos, Nina, Fink, Karen, Gilbert, Mark R.
發表在 Neuro Oncol (2015)

GENE-23. PREVIOUSLY IDENTIFIED COMMON GLIOMA RISK SNPs ARE ASSOCIATED WITH FAMILIAL GLIOMA

由 Ostrom, Quinn, Armstrong, Georgina, Amos, Christopher, Bernstein, Jonine, Claus, Elizabeth, Eckel-Passow, Jeanette, Il’yasova, Dora, Johansen, Christoffer, Lachance, Daniel, Lai, Rose, Merrell, Ryan, Olson, Sara, Schildkraut, Joellen, Shete, Sanjay, Houlston, Richard, Jenkins, Robert, Wrensch, Margaret, Melin, Beatrice, Barnholtz-Sloan, Jill, Bondy, Melissa
發表在 Neuro Oncol (2018)

ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

由 Gan, Hui K., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica, Fischer, JuDee, Ames, William, Xiong, Hao, Dudley, Matt, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Reardon, David A.
出版 2014

ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)...

由 Gan, Hui K., Kumthekar, Priya, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Papadopoulos, Kyriakos P., Scott, Andrew M., Gomez, Erica, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Lai, Rose, Reardon, David A.
發表在 Neuro Oncol (2015)

ATNT-02 DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING

由 Scott, Andrew M., Roberts-Rapp, Lisa, Gan, Hui K., Lu, Xin, Lassman, Andrew B., van den Bent, Martin, Papadopoulos, Kyriakos P., Merrell, Ryan, Kumthekar, Priya, Reardon, David A., Sokolova, Irina, Song, Minghao, Kular, Rupinder, Gomez, Erica, Fischer, JuDee, Bhathena, Anahita, Holen, Kyle, Lai, Rose, Ansell, Peter
發表在 Neuro Oncol (2015)

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

由 Reardon, David A., Lassman, Andrew B., van den Bent, Martin, Kumthekar, Priya, Merrell, Ryan, Scott, Andrew M., Fichtel, Lisa, Sulman, Erik P., Gomez, Erica, Fischer, JuDee, Lee, Ho-Jin, Munasinghe, Wijith, Xiong, Hao, Mandich, Helen, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Gan, Hui K.
發表在 Neuro Oncol (2017)

ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS

由 Puduvalli, Vinay, Wu, Jing, Yuan, Ying, Armstrong, Terri, Wu, Jimin, Giglio, Pierre, Xu, Jihong, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris, Iwamoto, Fabio, Tran, David, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas-Prado, Marta, Yung, W K Alfred, Gilbert, Mark
發表在 Neuro Oncol (2018)

ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

由 Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
發表在 Neuro Oncol (2015)

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

由 Puduvalli, Vinay K, Wu, Jing, Yuan, Ying, Armstrong, Terri S, Vera, Elizabeth, Wu, Jimin, Xu, Jihong, Giglio, Pierre, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris D, Tran, David, Iwamoto, Fabio, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas Prado, Marta, Yung, W K Alfred, Gilbert, Mark R
發表在 Neuro Oncol (2020)

EPID-01 CHICKEN POX AND GLIOMA RISK: PRELIMINARY RESULTS FROM THE GLIOGENE INTERNATIONAL CASE-CONTROL STUDY

由 Amirian, E. Susan, Scheurer, Michael, Armstrong, Georgina, Zhou, Renke, Lau, Ching, Claus, Elizabeth, Barnholtz-Sloan, Jill, Il'yasova, Dora, Schildkraut, Joellen, Ali-Osman, Francis, Sadetzki, Siegal, Johansen, Christoffer, Houlston, Richard, Jenkins, Robert, Lachance, Daniel, Olson, Sara, Bernstein, Jonine, Merrell, Ryan, Wrensch, Margaret, Davis, Faith, Lai, Rose, Shete, Sanjay, Amos, Christopher I., Melin, Beatrice S., Bondy, Melissa
發表在 Neuro Oncol (2015)